What did @true.lio actually say?
Honestly, not much, literally. The transcript is almost entirely a playful audio bit, something like "excuse me miss where's your waist" repeated over what is presumably a before-and-after visual transformation. The creator isn't making clinical claims here. They're celebrating a visible waist reduction, tagging a Miami med spa, and using the hashtag #tirzepatideweightloss. The implicit claim is that tirzepatide drove this body composition change.
That's actually a meaningful claim even if it's delivered through a jokey audio overlay. When you slap a GLP-1 drug hashtag on a body transformation video, you're telling your 14,000+ viewers: this medication did this to my body. That deserves scrutiny.
Does the science back this up?
Yes, tirzepatide does produce significant waist circumference reduction, and the data on this is pretty compelling. This isn't just weight loss. It's preferential fat mass reduction with relative lean mass preservation.
In the SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine), participants on the highest dose of tirzepatide (15 mg weekly) lost an average of 20.9% of their body weight over 72 weeks. Waist circumference dropped by an average of 14.4 cm in that group. That's a clinically meaningful reduction, not a rounding error. A separate body composition substudy found that roughly two-thirds of weight lost was fat mass, with visceral fat taking a disproportionate hit. So yes, a visibly changed waistline after tirzepatide treatment is biologically plausible and well-supported.
- Jastreboff et al., 2022, NEJM: 20.9% body weight reduction at 15 mg dose
- Waist circumference reduction averaged 14.4 cm in highest dose group
- Fat mass comprised approximately 66-68% of total weight lost
What did they get wrong (or right)?
There's nothing factually wrong here because there are no factual statements. The video is vibes and audio, not claims. Credit where it's due: not making medical claims is sometimes the right move on social media. But the hashtag framing does the work that words don't, and that's worth naming.
What the video can't tell you is anything about dose, duration, diet, exercise, starting weight, or whether surgical or aesthetic procedures also played a role. The Miami med spa tag is notable. Med spa environments vary widely in how they supervise GLP-1 prescribing, and "waist" transformations in that context sometimes involve more than medication alone. The video doesn't claim otherwise, but it doesn't clarify either. That ambiguity is misleading by omission, even if unintentionally.
The face comment, "your face is missing," is a casual nod to GLP-1-associated facial volume loss, sometimes called "Ozempic face" in the press. That phenomenon is real and documented, though it's a function of total fat loss, not a drug-specific effect (Hwang et al., 2023, JAMA Dermatology).
What should you actually know?
Tirzepatide is a dual GIP and GLP-1 receptor agonist, which separates it mechanistically from semaglutide. The dual agonism appears to drive larger fat loss than GLP-1 agonism alone, based on head-to-head data from the SURMOUNT-5 trial (Garvey et al., 2024, NEJM). Results like what this video appears to show, dramatic waist reduction, are within the range of what clinical trials report. But trials also show significant individual variability. Not everyone gets a 20% weight loss. Some people get 5%.
The facial volume loss shown in this video is common at high rates of weight loss regardless of mechanism. It's not dangerous, but patients should know it can happen. It's reversible with weight stabilization or dermal filler if desired.
If you're considering tirzepatide, it requires a prescription, medical supervision, and regular follow-up. Compounded tirzepatide is not equivalent to FDA-approved Zepbound or Mounjaro, and availability of compounded versions has shifted as the FDA shortage designation changed in 2025. A regulated telehealth provider with licensed prescribers is a safer starting point than a med spa with variable oversight.
Bottom line
This video shows a real outcome that real clinical data supports. It just doesn't tell you anything useful about how to get there, what the risks are, or what else might be going on. As GLP-1 content goes, it's neither harmful nor particularly informative. The science behind the transformation is solid. The video just isn't doing science.